Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT …
2020年4月18日 · Urothelial carcinomas of the upper urinary tract (UTUCs) are rare, with poorer stage-for-stage prognosis than urothelial carcinomas of the urinary bladder. No international …
Improved Disease-Free Survival With Adjuvant Chemotherapy …
2024年2月13日 · POUT was a phase III, randomized, open-label trial, including 261 patients with muscle-invasive or lymph node–positive, nonmetastatic upper tract urothelial cancer (UTUC) …
C++ 文件的读写 (fin && fout)_fin fout-CSDN博客
2018年7月17日 · 要通过一个流对象打开一个文件，我们使用它的成员 函数 open ()： void open (const char * filename, openmode mode); 这里filename 是一个字符串，代表要打开的文件 …
Updated outcomes of POUT: A phase III randomized trial of peri ...
2021年3月2日 · Here we present results of a pre-planned analysis updating the primary endpoint and reporting key secondary endpoints including overall survival.
Adjuvant chemotherapy improves OS in UTUC - Nature
2024年2月22日 · In 2020, adjuvant platinum-based chemotherapy became the standard of care for patients with muscle-invasive or locally advanced upper tract urothelial carcinoma of the …
ASCO GU 2021：上尿路尿路上皮癌的术后辅助化疗III期POUT试验结果更新 …
2021年2月16日 · POUT研究是一项针对UTUC患者术后接受辅助化疗与观察对比的多中心随机对照Ⅲ期临床试验，该研究旨在评估基于铂类药物的全身化疗对UTUC患者的临床获益。
POUT trial: Perioperative chemotherapy in upper tract urothelial ...
The POUT trial is the largest randomized control trial published, evaluating the efficacy of gemcitabine–platinum-based chemotherapy in UTUC, and it provides Level I support for ACT …
ASCO GU 2021: Updated Outcomes of POUT: A Phase III
2021年2月13日 · The primary endpoint was disease free survival and secondary endpoints included metastasis free survival, overall survival, toxicity, and patient-reported quality of life. …
Lancet ：术后化疗能降低肾癌复发一半的风险！-MedSci.cn
昨日，英国伦敦癌症研究所在《柳叶刀肿瘤》杂志上发表新研究，研究人员进行了全世界针对肾癌进行的最大规模试验——POUT试验，发现化学疗法使手术后复发罕见形式的肾癌的风险降低 …
The POUT (Peri-Operative chemotherapy versus sUrveillance in upper Tract urothelial cancer) trial aimed to assess the eficacy of systemic platinum-based chemotherapy in patients with …